![4,8-Dioxa-12,16-diazaheneicosanamide,6-amino-11,17-dioxo-6-[[3-oxo-3-[[3-[[1-oxo-5-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]pentyl]amino]propyl]amino]propoxy]Chemicalbookmethyl]-N-[3-[[1-oxo-5-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]pentyl]amino]propyl]-21-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]- structure, CAS 1159408-64-6](/structures/210000/200258_3_1159408_64_6.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1159408-64-6 |
| Catalog No. | 2A-1198366 |
| Chinese Name | Tri-GalNAc(OAc)3 |
| Molecular Formula | C79H128N10O36 |
| Molecular Weight | 1793.91 |
| Application | Tri-GalNAc(OAc)3 is a Tri-GalNAc ligand that can be used to synthesize GalNAc LYTAC. GalNAc LYTAC is involved in targeted protein degradation of the asialoglycoprotein receptor. TriGalNAc: triacetylga |
| SMILES | CC(=O)NC1C(OCCCCC(=O)NCCCNC(=O)CCOCC(N)(COCCC(=O)NCCCNC(=O)CCCCOC2OC(COC(C)=O)C(OC(C)=O)C(OC(C)=O)C2NC(C)=O)COCCC(=O)NCCCNC(=O)CCCCOC2OC(COC(C)=O)C(OC(C)=O)C(OC(C)=O)C2NC(C)=O)OC(COC(C)=O)C(OC(C)=O)C1OC(C)=O |
| InChI Key | VGHVGBJYGYFWED-PNPDLPPQSA-N |
| Transport Info | Product name: Tri-GalNAc(OAc)3 |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Octa(OtBu)-Glu(ɑ-OtBu)-AEEA-AEEA)-OR | 1169630-40-3 | 2A-1198357 |
| INDEX NAME NOT YET ASSIGNED | 2639221-78-4 | 2A-1198362 |
| (9H-Fluoren-9-yl)MethOxy]Carbonyl Ser(tBu)-Gly-OH | 81672-17-5 | 2A-1198363 |
| L-96 | 1159408-61-3 | 2A-1198364 |
| L96.TEA | 1159408-62-4 | 2A-1198365 |
| Thienamycin | 59995-64-1 | 2A-1198368 |
| 4-bromo-5-fluoro-2-methylbenzoic acid | 1349715-55-4 | 2A-2198375 |
| 4-bromo-3-fluoro-2-methylbenzoic acid | 1349716-97-7 | 2A-2198376 |
| 3-bromo-6-fluoro-2-methylbenzoic acid | 1427373-55-4 | 2A-2198377 |
| 3-bromo-4-fluoro-2-methylbenzoic acid | 503821-98-5 | 2A-2198378 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA